ImmunoCellular (IMUC:ASE) and Ampliphi Biosciences (APHB:ASE) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at

I have used the analysis tools on the website to generate some of the content of this blog post. These tools and reports are available for free at

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on AMEX

Today’s data is for companies listed on the American Stock Exchange.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEU Centrus Energy Corp 4.320000 9000000 None None 28.97 2.96
MSN Emerson Radio Corp 1.280000 27065852 None 0.6361 1.54 0.97
ALN American Lorain Corp 0.560000 38274490 56.0000 0.1089 0.98 -0.62
IMUC ImmunoCellular Therapeutics Ltd 1.610000 3449175 None 0.9056 3.32 None
NSPR InspireMD Inc 0.630200 6830070 None 1.0641 1.10 0.71
APHB Ampliphi Biosciences Corp 1.210000 1648812 None 0.2052 3.46 2.98

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

IMUC:ASE ImmunoCellular
ImmunoCellular has 9 employees and is headquartered in United States.
ImmunoCellular Therapeutics Ltd is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.

APHB:ASE Ampliphi Biosciences
Ampliphi Biosciences has 33 employees and is headquartered in United States.
Ampliphi Biosciences Corp is a biotechnology company engaged in the discovery, development and commercialization of novel phage therapeutics. The Company’s pipeline is based on the use of bacteriophages.

Free Valuation

Run a valuation on any of the companies listed above at or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.